Although chemotherapy drugs can be lifesaving for patients with cancer, they can be toxic to nurses and other health care personnel who handle them. Nurses should protect themselves through the use of proper handling techniques. A regular review of safe chemotherapy...
Cancer care entails a confusing labyrinth of screenings, tests, and treatments. This emerging role for nurses is becoming increasingly vital to achieve ideal patient outcomes.
Intramuscular injections offer improved treatment adherence, ease in monitoring of adverse effects, and multiple administration sites.
Diligent patient education that addresses adherence and persistence issues can optimize outcomes in patients with gastrointestinal stromal tumors.
In this second installment on disparate populations, the author focuses on the challenges to providing oncologic care to the black community.
What oncology nurses should understand about this ethnic group to provide culturally sensitive preventive care and treatment.
Administration, safety, and efficacy are similar in both agents. However, the frequency of administration makes a significant difference for patients.
An increased risk of coronary artery stenosis in cancer survivors may be a long-term posttreatment effect of chest radiotherapy.
New research is showing that sequence and timing have significant impact on the efficacy of therapeutic regimens that include bevacizumab.
A cancer diagnosis can cause high levels of distress. Nurses should assess patients frequently and know how to intervene promptly.
Successful implementation of survivorship programs can be impeded by institutional policies, physician attitudes, and patient perceptions.
Key studies presented at the 2011 Oncology Congress focus on treatments, prevention, and early diagnosis of GI tract cancers.
Targeted therapy, combination therapies, vaccines, and new treatment modalities demonstrate promising prognoses for these patients.
Nutritional status can have a significant impact on patients with cancer, and PN may help some patients respond better to treatment.
Disruptions in supply impact patient care. Nurses should know when to use a substitution drug and when to wait for the next shipment.
As more children survive pediatric cancers, oncology nurses are challenged to learn about past cancer histories.
Our ability to prevent acute CINV has improved greatly, but delayed CINV remains a problem.
Disease-specific advance care planning provides greater clarity about preferences, improving end-of-life care.
Conversations that encourage patients to explore their beliefs can improve both coping strategies and disease outcomes.
The ability to recognize the symptoms and manage the consequences are critical to personal and professional health.
Prognosis is not good, but many patients still seek treatment, equating prolonged neurologic function with better quality of life.
When planning for end-of-life care, disease-specific advance care planning delivers greater patient satisfaction and clarity about preferences.
Oncology nurses can do much to effectively use epidermal growth factor receptor inhibitors, a mainstay of lung cancer treatment.
What, how much, and when patients eat, as well as dietary supplement use, impact the efficacy of cancer therapy.
Developing an evidence-based oral care policy may help to prevent or to more effectively manage oral mucositis in oncology patients.
Hand-foot syndromes can greatly compromise quality of life. Aggressive management can prevent treatment disruption.
Outpatient treatment shortens hospital stays and shifts responsibility for patient care onto family members with no medical training.
Lymphedema diminishes function, causes chronic pain, and may make working impossible. Prevention is most effective.
Pain management is important for cancer patients during therapy and sometimes after treatment is completed—not just at the end of life.
Oncology nurses involved in clinical trials must understand the basics of cancer research and their practice's studies.
The recommendations of the US Preventive Services Task Force have generated considerable controversy but little practical change.
Plerixafor for stem cell transplantation, transdermal granisetron for nausea and vomiting, and everolimus for kidney cancer are profiled.
The most important thing, say the experts interviewed for this article, is for oncology nurses to reassure patients that they are not alone.
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|